Compare BOX & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BOX | TMDX |
|---|---|---|
| Founded | 2005 | 1998 |
| Country | United States | United States |
| Employees | N/A | 898 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.4B |
| IPO Year | 2014 | 2019 |
| Metric | BOX | TMDX |
|---|---|---|
| Price | $23.30 | $94.19 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 9 |
| Target Price | $35.57 | ★ $154.00 |
| AVG Volume (30 Days) | ★ 2.5M | 924.9K |
| Earning Date | 03-03-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 382.18 |
| EPS | 0.58 | ★ 4.87 |
| Revenue | $506,142,000.00 | ★ $605,494,000.00 |
| Revenue This Year | $9.41 | $24.51 |
| Revenue Next Year | $8.15 | $18.73 |
| P/E Ratio | $39.71 | ★ $20.37 |
| Revenue Growth | 26.98 | ★ 37.13 |
| 52 Week Low | $21.61 | $62.42 |
| 52 Week High | $38.80 | $156.00 |
| Indicator | BOX | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 41.33 | 21.84 |
| Support Level | $21.61 | N/A |
| Resistance Level | $33.30 | $131.86 |
| Average True Range (ATR) | 0.77 | 5.71 |
| MACD | -0.12 | -2.76 |
| Stochastic Oscillator | 14.37 | 2.61 |
Box is a cloud-based content management platform that provides storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file, sync, and share provider. Over time, it built out and acquired workflow and security tools to evolve the pure-play FSS business into a content management business. Most recently, Box has been pursuing an AI-powered, intelligent content management strategy that can allow for metadata extraction and workflow automation.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.